To the start page

8. E-Submission

8.1 When switching submission format from paper to eCTD or NeeS/VNeeS, do we have to submit a baseline submission? 

No. Baseline submissions are recommended, but not mandatory.

8.2  How do we know if an e-submission we’ve sent to the MPA is technically valid?

When an e-submission fails technical validation, we always contact the applicant with a request for a revised submission.

8.3 We have acquired an MA which was previously managed on eCTD/NeeS/VNeeS. Unfortunately, we have no means of creating eCTD:S/NeeS:s/VNeeS:s ourselves and would thus like to make submissions on paper. Is this acceptable to the MPA?

The MPA strongly recommends that an e-submission MA does not revert to a paper submission in case of an MAH transfer. Should this prove highly impractical for the new MAH, please contact us at esubmission@mpa.se for further discussion.

8.4 We currently make all submissions for a specific MA on NeeS:s. We now want to switch to eCTD submissions instead. Do we have to notify the MPA of this?

As our internal handling of eCTD:s and NeeS:s differs, we would appreciate if such a format change is mentioned in a separate passage on the first page of the cover letter for the first submission made in eCTD format.

8.5 Can we send PSUR:s electronically, without paper copies? 

Yes, this is acceptable for all products, even those for which you normally submit documentation on paper. Note that if the normal submission format for the MA:s concerned is eCTD or NeeS/VNeeS, then any PSUR submission should be made in the same format.

8.6 Do we have to use the same submission format for all strengths and/or pharmaceutical forms of a specific product (i.e. sharing the same trade name)? 

The MPA recommends that for ease of handling, the same submission format should be used for all MA:s of a given trade name. This is ultimately a decision for the applicant to make.

8.7 When will e-submissions to the MPA be mandatory? 

There are no such plans currently, nor do we plan on making the eCTD format mandatory for e-submissions.

8.8  Do the MPA require advance notice of a format switch from paper to any of the e-submission formats?

We always need confirmation that you intend to stop submitting documentation on paper in favour of an e-submission format, otherwise we might needlessly request paper copies. This confirmation should be made together with the first e-only submission. There is a form specifically for this purpose;

 Electronic submissions to the MPA (right-hand column).

 

 
 

Contact us

   
 
Medical Products Agency, P.O. Box 26, SE-751 03 Uppsala, SWEDEN | phone: +46 18 174600, fax: +46 18 548566 | Contact information